Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28804
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWillekens, B.-
dc.contributor.authorPresas-Rodriguez, S.-
dc.contributor.authorMansilla, M.-
dc.contributor.authorDerdelinckx, J.-
dc.contributor.authorLee, W. P.-
dc.contributor.authorNijs, G.-
dc.contributor.authorDe Laere, M.-
dc.contributor.authorWENS, Inez-
dc.contributor.authorCras, P.-
dc.contributor.authorParizel, P. M.-
dc.contributor.authorVan Hecke, W.-
dc.contributor.authorRibbens, A.-
dc.contributor.authorAdams, G.-
dc.contributor.authorCouttenye, M.-
dc.contributor.authorNavarro-Barriuso, J.-
dc.contributor.authorTeniente-Serra, A.-
dc.contributor.authorQuirant-Sanchez, B.-
dc.contributor.authorVerheij, H.-
dc.contributor.authorKip, A.-
dc.contributor.authorLopez-Diaz de Cerio, A.-
dc.contributor.authorInoges, S.-
dc.contributor.authorProsper, F.-
dc.contributor.authorGross, C. C.-
dc.contributor.authorWiendl, H.-
dc.contributor.authorVan Ham, S.-
dc.contributor.authorTen Brinke, A.-
dc.contributor.authorBarriocanal, A.-
dc.contributor.authorMassuet-Vilamajo, A.-
dc.contributor.authorHENS, Niel-
dc.contributor.authorBerneman, Z.-
dc.contributor.authorMartinez-Caceres, E.-
dc.contributor.authorCools, N.-
dc.contributor.authorRamo-Tello, C.-
dc.date.accessioned2019-07-24T13:56:41Z-
dc.date.available2019-07-24T13:56:41Z-
dc.date.issued2018-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 24, p. 679-680-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/28804-
dc.description.sponsorshipThis work was supported by the Methusalem Funding Program from the University of Antwerp, by an applied biomedical research project of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-TBM 140191), project PI14/01811, integrated in the Plan Nacional de I+D+I and co-supported by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER), Instituto de Salud Carlos III from Spain, Convocatoria AES 2016 and by the Belgian Charcot Foundation. Furthermore, the authors received funding from the European Union's Horizon 2020 research and innovation program under grant agreement number 779316.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleSafety and feasibility of a tolerogenic dendritic cell-based treatment of multiple sclerosis (MS): a collaborative initiative comparing intranodal and intradermal cell administration in two phase I clinical trials-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 10-12, 2018-
local.bibliographicCitation.conferencename34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceBerlin, GERMANY-
dc.identifier.epage680-
dc.identifier.spage679-
dc.identifier.volume24-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Willekens, B.; Derdelinckx, J.] Antwerp Univ Hosp, Dept Neurol, Antwerp, Belgium. [Willekens, B.; Derdelinckx, J.; Lee, W. P.; De Laere, M.; Wens, I.; Berneman, Z.; Cools, N.] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst, Lab Expt Hematol,VAXINFECTIO, Antwerp, Belgium. [Presas-Rodriguez, S.; Ramo-Tello, C.] Hosp Badalona Germans Trias & Pujol, Dept Neurosci, Multiple Sclerosis Unit, Badalona, Spain. [Presas-Rodriguez, S.] Univ Autonoma Barcelona, Dept Med, Cerdanyola Del Valles, Spain. [Mansilla, M.; Navarro-Barriuso, J.; Teniente-Serra, A.; Quirant-Sanchez, B.] Hosp Univ Germans Trias & Pujol & Res Inst, Div Immunol, Campus Can Ruti, Badalona, Spain. [Mansilla, M.; Navarro-Barriuso, J.; Teniente-Serra, A.; Quirant-Sanchez, B.; Martinez-Caceres, E.] Univ Autonoma Barcelona, Dept Cellular Biol Physiol & Immunol, Bellaterra, Spain. [Nijs, G.; Berneman, Z.] Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium. [Cras, P.] Antwerp Univ Hosp, Dept Neurol, Antwerp, Belgium. [Cras, P.] Univ Antwerp, Antwerp, Belgium. [Parizel, P. M.] Univ Antwerp, Dept Radiol, Antwerp, Belgium. [Parizel, P. M.] Antwerp Univ Hosp, Antwerp, Belgium. [Van Hecke, W.; Ribbens, A.] Icometrix, Leuven, Belgium. [Adams, G.] C Clear Partners, Mortsel, Belgium. [Couttenye, M.] Antwerp Univ Hosp, Dept Nephrol, Antwerp, Belgium. [Verheij, H.; Kip, A.] Lygature, Utrecht, Netherlands. [Lopez-Diaz de Cerio, A.; Inoges, S.; Prosper, F.] Univ Navarra, Haematol Cell Therapy Area, Pamplona, Spain. [Lopez-Diaz de Cerio, A.; Inoges, S.; Prosper, F.] Univ Navarra, Clin Univ Navarra, Immunol & Immunotherapy Dept, Pamplona, Spain. [Prosper, F.] Univ Navarra, CIMA, Program Haematol Oncol, Pamplona, Spain. [Gross, C. C.; Wiendl, H.] Univ Hosp, Dept Neurol, Munster, Germany. [Gross, C. C.; Wiendl, H.] Univ Munster, Munster, Germany. [Van Ham, S.; Ten Brinke, A.] Sanquin, Amsterdam, Netherlands. [Barriocanal, A.] Germans Trias & Pujol Hlth Sci Res Inst IGTP, Clin Res Polyvalent Unit, Badalona, Spain. [Barriocanal, A.] Spanish Clin Res Network SCReN, Clin Trial Unit, Badalona, Spain. [Barriocanal, A.] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles, Spain. [Massuet-Vilamajo, A.] Hosp Badalona Germans Trias & Pujol, Inst Diagnost Imatge, Badalona, Spain. [Hens, N.] Univ Antwerp, Ctr Evaluat Vaccinat, Antwerp, Belgium. [Hens, N.] Univ Hasselt, CENSTAT, Diepenbeek, Belgium. [Martinez-Caceres, E.] Hosp Badalona Germans Trias & Pujol, Div Immunol, Campus Can Ruti, Badalona, Spain.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000446861401548-
item.contributorWillekens, B.-
item.contributorPresas-Rodriguez, S.-
item.contributorMansilla, M.-
item.contributorDerdelinckx, J.-
item.contributorLee, W. P.-
item.contributorNijs, G.-
item.contributorDe Laere, M.-
item.contributorWENS, Inez-
item.contributorCras, P.-
item.contributorParizel, P. M.-
item.contributorVan Hecke, W.-
item.contributorRibbens, A.-
item.contributorAdams, G.-
item.contributorCouttenye, M.-
item.contributorNavarro-Barriuso, J.-
item.contributorTeniente-Serra, A.-
item.contributorQuirant-Sanchez, B.-
item.contributorVerheij, H.-
item.contributorKip, A.-
item.contributorLopez-Diaz de Cerio, A.-
item.contributorInoges, S.-
item.contributorProsper, F.-
item.contributorGross, C. C.-
item.contributorWiendl, H.-
item.contributorVan Ham, S.-
item.contributorTen Brinke, A.-
item.contributorBarriocanal, A.-
item.contributorMassuet-Vilamajo, A.-
item.contributorHENS, Niel-
item.contributorBerneman, Z.-
item.contributorMartinez-Caceres, E.-
item.contributorCools, N.-
item.contributorRamo-Tello, C.-
item.fulltextNo Fulltext-
item.fullcitationWillekens, B.; Presas-Rodriguez, S.; Mansilla, M.; Derdelinckx, J.; Lee, W. P.; Nijs, G.; De Laere, M.; WENS, Inez; Cras, P.; Parizel, P. M.; Van Hecke, W.; Ribbens, A.; Adams, G.; Couttenye, M.; Navarro-Barriuso, J.; Teniente-Serra, A.; Quirant-Sanchez, B.; Verheij, H.; Kip, A.; Lopez-Diaz de Cerio, A.; Inoges, S.; Prosper, F.; Gross, C. C.; Wiendl, H.; Van Ham, S.; Ten Brinke, A.; Barriocanal, A.; Massuet-Vilamajo, A.; HENS, Niel; Berneman, Z.; Martinez-Caceres, E.; Cools, N. & Ramo-Tello, C. (2018) Safety and feasibility of a tolerogenic dendritic cell-based treatment of multiple sclerosis (MS): a collaborative initiative comparing intranodal and intradermal cell administration in two phase I clinical trials. In: MULTIPLE SCLEROSIS JOURNAL, 24, p. 679-680.-
item.accessRightsClosed Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Show simple item record

Page view(s)

52
checked on Jul 31, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.